These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 19075764)

  • 1. Sirtuin modulators: targets for metabolic diseases and beyond.
    Szczepankiewicz BG; Ng PY
    Curr Top Med Chem; 2008; 8(17):1533-44. PubMed ID: 19075764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dichotomous Sirtuins: Implications for Drug Discovery in Neurodegenerative and Cardiometabolic Diseases.
    Gomes P; Leal H; Mendes AF; Reis F; Cavadas C
    Trends Pharmacol Sci; 2019 Dec; 40(12):1021-1039. PubMed ID: 31704173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Sirtuin family: therapeutic targets to treat diseases of aging.
    Milne JC; Denu JM
    Curr Opin Chem Biol; 2008 Feb; 12(1):11-7. PubMed ID: 18282481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirtuin functions and modulation: from chemistry to the clinic.
    Carafa V; Rotili D; Forgione M; Cuomo F; Serretiello E; Hailu GS; Jarho E; Lahtela-Kakkonen M; Mai A; Altucci L
    Clin Epigenetics; 2016; 8():61. PubMed ID: 27226812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biology, Chemistry, and Pharmacology of Sirtuins.
    Bedalov A; Chowdhury S; Simon JA
    Methods Enzymol; 2016; 574():183-211. PubMed ID: 27423863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SIRTUIN 1: regulating the regulator.
    Zschoernig B; Mahlknecht U
    Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sirtuins: novel targets for metabolic disease.
    Elliott PJ; Jirousek M
    Curr Opin Investig Drugs; 2008 Apr; 9(4):371-8. PubMed ID: 18393104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirtuin modulators: mechanisms and potential clinical implications.
    Sanchez-Fidalgo S; Villegas I; Sanchez-Hidalgo M; de la Lastra CA
    Curr Med Chem; 2012; 19(15):2414-41. PubMed ID: 22455589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirtuin-targeting drugs: Mechanisms of action and potential therapeutic applications.
    Aljada A; Dong L; Mousa SA
    Curr Opin Investig Drugs; 2010 Oct; 11(10):1158-68. PubMed ID: 20872319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sirtuin activators and inhibitors.
    Villalba JM; Alcaín FJ
    Biofactors; 2012; 38(5):349-59. PubMed ID: 22730114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence supporting a mechanistic role of sirtuins in mood and metabolic disorders.
    Alageel A; Tomasi J; Tersigni C; Brietzke E; Zuckerman H; Subramaniapillai M; Lee Y; Iacobucci M; Rosenblat JD; Mansur RB; McIntyre RS
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():95-101. PubMed ID: 29802856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of activators and inhibitors of sirtuins.
    Balcerczyk A; Pirola L
    Biofactors; 2010; 36(5):383-93. PubMed ID: 20848588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases.
    Imai S; Guarente L
    Trends Pharmacol Sci; 2010 May; 31(5):212-20. PubMed ID: 20226541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
    Huber K; Superti-Furga G
    Bioorg Med Chem; 2011 Jun; 19(12):3616-24. PubMed ID: 21306906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirtuin modulators: an updated patent review (2012 - 2014).
    Mellini P; Valente S; Mai A
    Expert Opin Ther Pat; 2015 Jan; 25(1):5-15. PubMed ID: 25435179
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of NAD+ dependent histone deacetylases (sirtuins).
    Neugebauer RC; Sippl W; Jung M
    Curr Pharm Des; 2008; 14(6):562-73. PubMed ID: 18336301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sirtuin modulators.
    Mahajan SS; Leko V; Simon JA; Bedalov A
    Handb Exp Pharmacol; 2011; 206():241-55. PubMed ID: 21879453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seven sirtuins for seven deadly diseases of aging.
    Morris BJ
    Free Radic Biol Med; 2013 Mar; 56():133-71. PubMed ID: 23104101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sirtuins: multifaceted drug targets.
    Chakrabarty SP; Balaram H; Chandrasekaran S
    Curr Mol Med; 2011 Dec; 11(9):709-18. PubMed ID: 21999152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overview of Sirtuins as potential therapeutic target: Structure, function and modulators.
    Wang Y; He J; Liao M; Hu M; Li W; Ouyang H; Wang X; Ye T; Zhang Y; Ouyang L
    Eur J Med Chem; 2019 Jan; 161():48-77. PubMed ID: 30342425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.